Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 820027 MINNEAPOLIS, MN
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$713,821
+$699,378 QoQ
Shares Held
626,160
+5926.0% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 170 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 0% Shared 99% None 1%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $802,494,373 across 36 Drug Manufacturers - Specialty & Generic names. AKBA ranks #29 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 18,815,747 $298,794,060
2 NBIX
Neurocrine Biosciences Inc
 502,267 $84,652,078
3 LNTH
Lantheus Holdings, Inc.
 619,298 $68,704,917
4 UTHR
UNITED THERAPEUTICS Corp
 123,215 $66,761,581
5 ZTS
Zoetis Inc.
 812,181 $58,363,324
6 ELAN
Elanco Animal Health Inc
 1,396,427 $34,366,066
7 ALKS
Alkermes plc.
 630,325 $33,029,029
8 AMRX
Amneal Pharmaceuticals, Inc.
 1,581,869 $27,382,151

All Filings in AKBA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $713,821 626,160
2026-03-31 $14,443 10,391
2025-12-31 $17,703 10,996
2025-09-30 $28,872 10,576
2025-06-30 $644,089 176,948
2025-03-31 $23,139 12,052
2024-12-31 $22,735 11,966
2022-12-31 $94,280 163,400
2022-09-30 $52,087 164,835
2022-06-30 $3,952 11,198
2021-12-31 $23,840 10,549
2021-09-30 $44,055 15,297
2021-06-30 $207,983 54,877
2021-03-31 $69,382 20,497
2020-12-31 $48,941 17,479
2020-09-30 $42,815 17,058
2020-06-30 $1,816,528 133,765
2020-03-31 $295,134 38,936